Minerva Neurosciences, Inc.NERVNASDAQ

Revenue (LTM)

Net Income (LTM)

$-293M

-20492.7% YoY

Free Cash Flow

$-13.5B

Revenue CAGR (5Y)

—

—Marginsstable

FCF($13.5B)

Now unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-0
Operating Income	-45	-25↑44.4%	-23↑8.4%	-22↑5.5%	-15↑30.9%
Net Income	-50	-32↑35.7%	-30↑6.6%	1↑104.8%	-293↓20492.7%
EBITDA	-45	-25↑45.5%	-22↑12.2%	6↑127.8%	-15↓350.7%
EPS Diluted	-9.35	-6.01↑35.7%	-4.61↑23.3%	0.19↑104.1%	-34.67↓18347.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	61	36↓40.6%	41↑13.4%	21↓47.8%	82↑285.3%
Total Current Assets	62	40↓35.4%	42↑4.6%	22↓47.0%	83↑273.2%
Total Assets	77	55↓28.6%	57↑3.3%	37↓34.7%	98↑163.8%
Total Current Liabilities	3	1↓51.1%	3↑142.5%	3↓15.1%	2↓19.3%
Total Liabilities	69	75↑8.6%	85↑13.6%	63↓26.4%	239↑279.9%
Total Equity	8	-20↓351.1%	-28↓42.1%	-26↑9.7%	-141↓447.8%
Total Debt	0	0	0	0	65
Net Debt	-61	-36↑40.6%	-41↓13.4%	-21↑47.8%	-17↑18.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-25	-25↓0.2%	-15↑40.0%	-20↓32.2%	-13,511↓69007.6%
Capital Expenditure	0	-0	0	0	0
Free Cash Flow	-25	-25↓0.2%	-15↑40.0%	-20↓32.2%	-13,511↓69007.6%
Stock-Based Comp	5	4↓21.3%	2↓52.1%	1↓32.7%	1,327↑100039.3%
Net Change in Cash	35	-25↓169.7%	5↑119.5%	-20↓505.7%	60,940↑311803.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance